Sophia Genetics SA (NAS:SOPH)
$ 3.65 -0.34 (-8.52%) Market Cap: 242.50 Mil Enterprise Value: 200.98 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 56/100

Q3 2022 Sophia Genetics SA Earnings Presentation Transcript

Nov 08, 2022 / 01:30PM GMT
Release Date Price: $1.84 (-5.15%)
Operator

Presentation
Nov 08, 2022 / 01:30PM GMT

=====================
Corporate Participants
=====================
* Jennifer Pottage
SOPHiA GENETICS SA - Head of IR
* Jurgi Camblong
SOPHiA GENETICS SA - Co-Founder, CEO & Director
* Philippe Menu
SOPHiA GENETICS SA - Senior VP & Chief Medical Officer
* Ross Jordan Muken
SOPHiA GENETICS SA - Senior VP & CFO

=====================
Conference Call Participants
=====================
* Kyle Boucher
Cowen and Company, LLC, Research Division - Associate
* Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst
* Vidyun Bais
BTIG, LLC, Research Division - Research Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot